sd-np-gt8
Vaccineexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 10, 2023 (NCT05781542)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05781542 | Phase 1 | Apr 10, 2023 | Access to Advanced Health Institute (AAHI), Department of Health and Human Services, HIV Vaccine Trials Network, Inovio Pharmaceuticals, National Institute of Allergy and Infectious Diseases (NIAID), The Wistar Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Access to Advanced Health Institute (AAHI) | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2023 |
| HIV Vaccine Trials Network | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Inovio Pharmaceuticals | For profit | 1 | 0 | 1 | 2023 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2023 |
| The Wistar Institute | Academic/Hospital | 1 | 0 | 1 | 2023 |
6 organizations
Page 1 / 1